Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis

Stem Cells

Volumn 30, Issue 5, 2012, Pages 1030-1041

  Eirin, Alfonso ^a   Zhu, Xiang Yang ^a   Krier, James D ^a   Tang, Hui ^a   Jordan, Kyra L ^a   Grande, Joseph P ^a   Lerman, Amir ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Progenitor cells; Renal artery stenosis; Renal hypertension; Revascularization

Indexed keywords

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC RENAL ARTERY STENOSIS; CONTROLLED STUDY; EX VIVO STUDY; EXPERIMENTAL PIG; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY; REVASCULARIZATION; STENT;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; BLOOD PRESSURE; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; INFLAMMATION; KIDNEY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OXIDATIVE STRESS; RENAL ARTERY OBSTRUCTION; SWINE;

SUIDAE;

EID: 84860503318     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1047     Document Type: Article

References (55)

1. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344: 431-442. (Pubitemid 32128677)
2. Hansen KJ, Edwards MS, Craven TE et al. Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002; 36:443-451.
3. Conlon PJ, Little MA, Pieper K et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001;60:1490-1497. (Pubitemid 32960044)
4. Bax L, Woittiez AJ, Kouwenberg HJ et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial. Ann Intern Med 2009;150:840-848, W150-841.
5. Wheatley K, Ives N, Gray R et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953-1962.
6. Favreau F, Zhu XY, Krier JD et al. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int 2010;78:1110-1118.
7. Eirin A, Zhu XY, Urbieta Caceres VH et al. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol 2011;300:F1394-F1401.
8. Chade AR, Zhu X, Lavi R et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009;119:547-557.
9. Chade AR, Zhu XY, Krier JD et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 2010;28:1039-1047.
10. Asanuma H, Meldrum DR, Meldrum KK. Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 2010;184:26-33.
11. Marigo I, Dazzi F. The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol 2011;33:593-602.
12. Morigi M, Imberti B, Zoja C et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:1794-1804. (Pubitemid 38822058)
13. Rognant N, Rouviere O, Janier M et al. Hemodynamic responses to acute and gradual renal artery stenosis in pigs. Am J Hypertens 2010; 23:1216-1219.
14. Chade AR, Rodriguez-Porcel M, Grande JP et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002; 106:1165-1171. (Pubitemid 34970861)
15. Chade AR, Rodriguez-Porcel M, Grande JP et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003;23:1295-1301. (Pubitemid 36871287)
16. Urbieta-Caceres VH, Zhu X-Y, Jordan KL et al. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis 2011 (in press).
17. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens 2010;23:1159-1169.
18. Isles CG, Robertson S, Hill D. Management of renovascular disease: A review of renal artery stenting in ten studies. QJM 1999;92:159-167. (Pubitemid 29116952)
19. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: Clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003;226:821-826. (Pubitemid 36259160)
20. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195:229-235. (Pubitemid 32899033)
21. Kale S, Karihaloo A, Clark PR et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112:42-49. (Pubitemid 38056374)
22. Togel F, Hu Z, Weiss K et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005;289:F31-F42. (Pubitemid 40863570)
23. Morigi M, Benigni A, Remuzzi G et al. The regenerative potential of stem cells in acute renal failure. Cell Transplant 2006;15(suppl 1):S111-S117.
24. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4a3-deficient mice. Kidney Int 2006;70:121-129. (Pubitemid 44000128)
25. Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: Ischemia and beyond. Prog Cardiovasc Dis 2009; 52:196-203.
26. Kim WS, Park BS, Kim HK et al. Evidence supporting antioxidant action of adipose-derived stem cells: Protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008;49:133-142.
27. Lanza C, Morando S, Voci A et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 2009;110:1674-1684.
28. Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000;34:185-194. (Pubitemid 30320963)
29. Togel F, Zhang P, Hu Z et al. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 2009;13:2109-2114.
30. Ohtani K, Usui M, Nakano K et al. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys. Gene Ther 2004;11:1273-1282. (Pubitemid 39173434)
31. Shoji M, Oskowitz A, Malone CD et al. Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines. J Atheroscler Thromb 2011;18:464-474.
32. McTaggart SJ, Atkinson K. Mesenchymal stem cells: Immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton) 2007;12:44-52.
33. Brunswig-Spickenheier B, Boche J, Westenfelder C et al. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. Stem Cells Dev 2010;19:719-729.
34. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of cd44 following acute tubular injury. Kidney Int 2007;72:430-441. (Pubitemid 47237610)
35. Truong LD, Farhood A, Tasby J et al. Experimental chronic renal ischemia: Morphologic and immunologic studies. Kidney Int 1992;41:1676-1689.
36. Wright JR, Duggal A, Thomas R et al. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: Implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001;16:765-770. (Pubitemid 32257973)
37. Chen R, Novick AC, Pohl M. Reversible renin mediated massive proteinuria successfully treated by nephrectomy. J Urol 1995;153:133-134. (Pubitemid 24379816)
38. Asanuma H, Vanderbrink BA, Campbell MT et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res 2011;168:e51-e59.
39. Liu H, McTaggart SJ, Johnson DW et al. Original article anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury. Cytotherapy 2012;14:162-172.
40. Roldan M, Macias-Gonzalez M, Garcia R et al. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 2011;25:4111-4126.
41. Huang XP, Sun Z, Miyagi Y et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their longterm benefits for myocardial repair. Circulation 2010;122:2419-2429.
42. Wu X, Huang L, Zhou Q et al. Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth. Int J Cardiol 2005;105:274-282. (Pubitemid 41605076)
43. Hashi CK, Zhu Y, Yang GY et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci USA 2007;104:11915-11920. (Pubitemid 47185605)
44. Mirza A, Hyvelin JM, Rochefort GY et al. Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. J Vasc Surg 2008;47:1313-1321.
45. Ponte AL, Marais E, Gallay N et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007;25:1737-1745. (Pubitemid 47121852)
46. Chade AR, Zhu X, Mushin OP et al. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J 2006;20:1706-1708.
47. Zhu XY, Chade AR, Krier JD et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009;27:2063-2073.
48. Devine SM, Cobbs C, Jennings M et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001. (Pubitemid 36857986)
49. Lavi R, Zhu XY, Chade AR et al. Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2010;30:976-983.
50. Daghini E, Primak AN, Chade AR et al. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: Comparison with electron-beam CT. Radiology 2007;243:405-412. (Pubitemid 46649695)
51. Chade AR, Krier JD, Rodriguez-Porcel M et al. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am J Physiol Renal Physiol 2004;286:F1079-F1086. (Pubitemid 38656363)
52. Zhu XY, Chade AR, Rodriguez-Porcel M et al. Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004;24:1854-1859. (Pubitemid 39350303)
53. Zhu XY, Rodriguez-Porcel M, Bentley MD et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004;109:2109-2115. (Pubitemid 38620220)
54. Zhu XY, Daghini E, Chade AR et al. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol 2007;18:1209-1217. (Pubitemid 46536907)
55. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers cd31, cd34, Von Willebrand factor, and fli-1 in normal human tissues. J HistochemCytochem 2006;54:385-395.